NO175372C - Analogifremgangsmåte for framstilling av et terapeutisk aktivt polypeptid - Google Patents

Analogifremgangsmåte for framstilling av et terapeutisk aktivt polypeptid

Info

Publication number
NO175372C
NO175372C NO891572A NO891572A NO175372C NO 175372 C NO175372 C NO 175372C NO 891572 A NO891572 A NO 891572A NO 891572 A NO891572 A NO 891572A NO 175372 C NO175372 C NO 175372C
Authority
NO
Norway
Prior art keywords
preparing
therapeutically active
active polypeptide
analogous method
same
Prior art date
Application number
NO891572A
Other languages
English (en)
Norwegian (no)
Other versions
NO891572L (no
NO175372B (no
NO891572D0 (no
Inventor
Takanori Nakamura
Sadaaki Iwanaga
Motonori Ohno
Kyosuke Miyazaki
Original Assignee
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd
Publication of NO891572D0 publication Critical patent/NO891572D0/no
Publication of NO891572L publication Critical patent/NO891572L/no
Priority to NO940078A priority Critical patent/NO178663C/no
Publication of NO175372B publication Critical patent/NO175372B/no
Publication of NO175372C publication Critical patent/NO175372C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO891572A 1987-08-21 1989-04-18 Analogifremgangsmåte for framstilling av et terapeutisk aktivt polypeptid NO175372C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO940078A NO178663C (no) 1987-08-21 1994-01-10 Framgangsmåte for framstilling av et terapeutisk aktivt polypeptid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20625887 1987-08-21
PCT/JP1988/000823 WO1989001492A1 (fr) 1987-08-21 1988-08-19 Nouveau polypeptide et procede de prepration

Publications (4)

Publication Number Publication Date
NO891572D0 NO891572D0 (no) 1989-04-18
NO891572L NO891572L (no) 1989-05-09
NO175372B NO175372B (no) 1994-06-27
NO175372C true NO175372C (no) 1994-10-05

Family

ID=16520353

Family Applications (2)

Application Number Title Priority Date Filing Date
NO891572A NO175372C (no) 1987-08-21 1989-04-18 Analogifremgangsmåte for framstilling av et terapeutisk aktivt polypeptid
NO940078A NO178663C (no) 1987-08-21 1994-01-10 Framgangsmåte for framstilling av et terapeutisk aktivt polypeptid

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO940078A NO178663C (no) 1987-08-21 1994-01-10 Framgangsmåte for framstilling av et terapeutisk aktivt polypeptid

Country Status (13)

Country Link
US (2) US5068314A (fr)
EP (1) EP0343248B1 (fr)
JP (1) JP2710653B2 (fr)
KR (1) KR970001811B1 (fr)
CN (1) CN1031193C (fr)
AT (1) ATE88480T1 (fr)
AU (1) AU642089B2 (fr)
CA (2) CA1337781C (fr)
DE (1) DE3880481T2 (fr)
DK (1) DK193589A (fr)
FI (1) FI92708C (fr)
NO (2) NO175372C (fr)
WO (1) WO1989001492A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337781C (fr) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide provenant de la limule, manifestant de l'affinite pour les lipopolysaccharides; methode de preparation
US5594113A (en) * 1988-06-23 1997-01-14 Associates Of Cape Cod, Inc. Endotoxin binding and neutralizing protein and uses thereof
ES2081491T3 (es) * 1990-09-11 1996-03-16 Seikagaku Kogyo Co Ltd Nuevo polipeptido y farmaco anti-vih preparado a partir de este polipeptido.
EP0549102B1 (fr) * 1991-12-25 1996-07-03 Maruha Corporation Réactifs et procédés pour déterminer des Beta-Glucanes
JP3361830B2 (ja) * 1992-03-30 2003-01-07 生化学工業株式会社 抗菌性組成物及びそれを有効成分とする薬剤
ATE152734T1 (de) * 1992-05-30 1997-05-15 Sikiric Predrag Bpc-peptide, deren herstellung und verwendung
JP3402476B2 (ja) * 1992-08-24 2003-05-06 生化学工業株式会社 リポ多糖結合性タンパク質及びその製造法
CA2112776C (fr) * 1993-01-21 2002-11-12 Masakazu Tsuchiya Methode pour inhiber l'activite d'une endotoxine
WO1995005393A2 (fr) 1993-08-18 1995-02-23 Morphosys Gesellschaft Für Proteinoptimierung Mbh Peptides liant et neturalisant les lipopolysaccharides
CN1038841C (zh) * 1993-10-14 1998-06-24 生化学工业株式会社 新型多肽以及由其制备的抗人类免疫缺陷病毒制剂
KR100257310B1 (ko) * 1996-12-21 2000-05-15 정몽규 트렁크 리드 개폐장치
US6011066A (en) * 1998-02-02 2000-01-04 Veterans General Hospital-Taipei Method for treating septic shock
CN100389140C (zh) * 2006-05-12 2008-05-21 北京理工大学 由聚肽-b-聚四氢呋喃-b-聚肽三嵌段共聚物制备纳米及微米级自组装体的方法
WO2011008863A2 (fr) * 2009-07-14 2011-01-20 Lucia Irene Gonzalez Peptides stéréoisomères et leurs conjugués polymères pour infection par le vih
CN108623659B (zh) * 2018-03-17 2021-09-14 中国海洋大学 一种氨基酸全部选用d型氨基酸的抗菌肽合成方法
WO2021183061A1 (fr) * 2020-03-13 2021-09-16 Vet Products Research And Innovation Center Company Limited Peptides antimicrobiens pour l'inhibition de micro-organismes pathogènes dans les voies digestives et respiratoires chez l'animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663435A (en) * 1982-12-06 1987-05-05 Merck & Co., Inc. Bridged cyclic hexapeptide somatostatin analogs
CA1337781C (fr) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide provenant de la limule, manifestant de l'affinite pour les lipopolysaccharides; methode de preparation

Also Published As

Publication number Publication date
JPH02500194A (ja) 1990-01-25
NO891572L (no) 1989-05-09
KR970001811B1 (ko) 1997-02-15
FI92708B (fi) 1994-09-15
KR890701624A (ko) 1989-12-21
DK193589A (da) 1989-06-16
AU620345B2 (en) 1992-02-20
EP0343248A1 (fr) 1989-11-29
FI92708C (fi) 1994-12-27
US5068314A (en) 1991-11-26
NO175372B (no) 1994-06-27
WO1989001492A1 (fr) 1989-02-23
AU642089B2 (en) 1993-10-07
CA1337781C (fr) 1995-12-19
CA1337782C (fr) 1995-12-19
FI891873A0 (fi) 1989-04-19
EP0343248B1 (fr) 1993-04-21
JP2710653B2 (ja) 1998-02-10
DK193589D0 (da) 1989-04-20
AU1702892A (en) 1992-07-16
CN1031193C (zh) 1996-03-06
NO940078L (no) 1989-05-09
US5416194A (en) 1995-05-16
CN1031379A (zh) 1989-03-01
NO178663B (no) 1996-01-29
DE3880481D1 (de) 1993-05-27
FI891873A (fi) 1989-04-19
DE3880481T2 (de) 1993-09-09
AU2311388A (en) 1989-03-09
NO940078D0 (no) 1994-01-10
ATE88480T1 (de) 1993-05-15
NO178663C (no) 1996-05-08
NO891572D0 (no) 1989-04-18

Similar Documents

Publication Publication Date Title
NO175372C (no) Analogifremgangsmåte for framstilling av et terapeutisk aktivt polypeptid
EP0341915A3 (fr) Peptides antiagrégatifs
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
DE69128664D1 (de) CNP-Gen und Vorläuferprotein aus Schwein
AU1377092A (en) Peptides for treatment
Craig et al. Purity studies on polypeptide antibiotics: bacitracin
Kuromizu et al. Reexamination of the primary structure of an antitumor protein, neocarzinostatin
AU671989B2 (en) Treatment of tropical spastic paresis with peptide T
AU1599892A (en) Novel polypeptides with affinity to lipopolysaccharides and their uses
AU585167B2 (en) Novel substrate peptides
RU94024392A (ru) Минерально-аминокислотный концентрат
RU94046096A (ru) Линейные или циклические пептиды, их применение, способы лечения и конъюгаты пептидов
KR790001842B1 (ko) 신규 폴리펩티드의 제조법
DE69813232D1 (de) Wespe pompilid neuropeptide
UA28084C2 (uk) Протипухлинний засіб, виділений з слизової кишечника, спосіб його виділення
SE8006333L (sv) Polypeptid psp och salter derav
RU97114945A (ru) Белки против ожирения

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2003